98%
921
2 minutes
20
Matsushima Grading System has been widely used to evaluate vessel ingrowth after bypass procedures for patients with Moyamoya disease (MMD). However, Matsushima is notably subjective and prone to measurement variability among clinicians. To address these limitations, the Orbital Grading System was developed as an objective approach to assess collateralization after EDAS, utilizing orbital craniometric landmarks to segment the ipsilateral skull into three distinct regions. The current study compares the interrater reliability of both scales. Six physicians, including two attending hybrid-neurovascular surgeons, one interventional neurologist, one neurointerventional radiologist and two vascular neurosurgery fellows, independently graded digital subtraction angiography (DSA) images from 37 hemispheres of MMD-patients using both the Matsushima and Orbital Grading scales. Fleiss'-kappa was used to assess inter-rater agreement for each scale, with results interpreted according to Landis-and-Koch-agreement-scale. All six raters graded 37 DSA-images using both Matsushima and the Orbital grading systems. Both scales demonstrated statistically significant inter-rater agreement (p < 0.0001). However, the Orbital Grading System produced significantly higher agreement (Kappa:0.83 [95%CI:0.74-0.93], indicating almost-perfect-agreement) compared to Matsushima grading system (Kappa:0.52 [95%CI:0.38-0.65], indicating moderate-agreement). Simple percentage agreement among all raters was 81.1% in the Orbital Grading System and 48.6% in Matsushima Grading. The Orbital Grading System demonstrates superior interrater reliability compared to the Matsushima grading, with significantly higher agreement among raters. This suggests that the Orbital Grading System is a more consistently objective tool for evaluating collateralization following EDAS. By reducing grading discrepancies between observers and enhancing generalizability, this system has the potential to optimize the management of MMD. Although our study demonstrates excellent reproducibility of the Orbital Grading System, future studies are needed to validate its accuracy in reflecting the true extent and functional significance of postoperative collateral formation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10143-025-03660-5 | DOI Listing |
Knee Surg Sports Traumatol Arthrosc
September 2025
Department of Orthopaedics, Hillel Yaffe Medical Center (HYMC), Hadera, Clinic, Tel-Aviv, Israel.
Purpose: This European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA) formal consensus aims to provide evidence- and expert opinion-based recommendations for the use of point-of-care- and expanded-cell-based therapy (CBT) in the treatment of knee osteoarthritis (OA), focusing on indications, preparation, and administration.
Methods: A multidisciplinary group of 77 leading experts in musculoskeletal regenerative medicine from 22 European Countries formed a steering group, a rating group, and a reader group. The steering group developed 23 questions, originating from 27 statements.
Orbit
September 2025
Adnexal, Moorfields Eye Hospital, London, UK.
Purpose: To evaluate the real-world efficacy, safety, and outcomes of cemiplimab for advanced periocular conjunctival and cutaneous squamous cell carcinoma (SCC).
Methods: Retrospective case series of adults treated with cemiplimab for periocular conjunctival or cutaneous SCC at Moorfields Eye Hospital (2021-2025).
Results: We included 9 patients (mean age 66, range 43-79; 56% female; 78% Caucasian).
Cureus
July 2025
Division of Transfusion and Cell Therapy, Department of Hematology and Oncology, Okayama University Hospital, Okayama City, JPN.
Follicular lymphoma mostly takes an indolent course, and thus, observation with watchful waiting is a main therapeutic strategy. Recent long-term studies suggest earlier treatment with rituximab monotherapy may benefit patients by delaying the need for treatment in the later phase of exacerbation. In this study, we reported a patient with bilateral orbital follicular lymphoma who received four-time weekly rituximab monotherapy as an induction therapy only and maintained the remission for 5 years with no treatment.
View Article and Find Full Text PDFBrain Sci
August 2025
Neuro-Oncology, Moffitt Cancer Center, Tampa, FL 33612, USA.
Optic pathway glioma (OPG) is a rare pediatric low-grade glioma, frequently associated with neurofibromatosis type 1 (NF-1), that presents unique therapeutic challenges due to its anatomical location and its potential to impair vision, endocrine function, and developmental trajectories. Current clinical management prioritizes a multidisciplinary, patient-specific approach aimed at tumor control while preserving long-term quality of life. Strategies vary based on clinical presentation, ranging from observation in asymptomatic cases to chemotherapy for progressive or symptomatic tumors.
View Article and Find Full Text PDFAesthetic Plast Surg
August 2025
Department of Plastic and Reconstructive Surgery, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, 1 Singillo, Yongdeongpo-gu, Seoul, 07441, Republic of Korea.
Background: The subbrow approach is reportedly more effective than upper blepharoplasty for improving lateral hooding. Additionally, it allows for the removal of thick periorbital fat while simultaneously tightening weakened and sagging orbicularis oculi muscles. This study introduces a method for repositioning and redistributing the medial fat pad to the central area, restoring fullness in the central area, and improving medial upper eyelid bulging.
View Article and Find Full Text PDF